In the third quarter of this year, Tonix will discuss Phase II trial design to assess the drug for long Covid with the US FDA.
Humanigen, which previously sought EUA from the US FDA for lenzilumab to treat Covid-19, is seeking marketing approval by the MHRA for the drug.
With digital transformation gradually picking up pace, the pharmaceutical industry has witnessed an increase in investment in emerging technologies.
The pharmaceutical industry believes that the top management of a company plays a crucial role in digital transformation.
Trial that pits Covid-19 monoclonal antibodies to weigh efficacy signals recruits 1,500 participants, with an interim analysis expected shortly
An investigator-led Phase III trial comparing authorised monoclonal antibodies (mAbs) from Eli Lilly and Regeneron Pharmaceuticals to treat Covid-19 has recruited approximately 1,500 participants to date, said investigator Dr David Huang, professor of Critical Care...